BM Hyrunidase

BM Hyrunidase Injection is a solution that contains 1,500 International Units (IU) of hyaluronidase per 1 mL. Hyaluronidase is an enzyme that temporarily breaks down hyaluronic acid in the body, which increases tissue permeability. This process helps other injected medications and fluids spread and be absorbed more effectively, improving treatment outcomes.

Key Features:

• Active Ingredient: 1,500 IU of hyaluronidase per 1 mL.

Primary Uses:

• Enhances the absorption and distribution of subcutaneous or intramuscular injections, including local anesthetics.
• Aids in the reabsorption of excess fluids and blood in tissues, helping to reduce swelling and hematomas.

Packaging: Available in packs of 10 vials per case.

Clinical Applications:

• Improved Drug Delivery: By increasing tissue permeability, BM Hyrunidase enhances the absorption of co-administered medications, leading to better therapeutic results.
• Edema and Hematoma Management: It helps reabsorb excess fluids and blood, reducing swelling and speeding up recovery.

Administration Guidelines:

• Dosage: A healthcare professional should determine the appropriate dosage based on the specific clinical needs.
• Method: BM Hyrunidase can be administered via subcutaneous or intramuscular injection, either alone or mixed with other injectable solutions, as directed.

Safety and Precautions:

• Contraindications: Not recommended for use in patients with a known hypersensitivity to hyaluronidase or any component of the formulation.
• Adverse Reactions: Potential side effects may include localized reactions at the injection site. Patients should be monitored for adverse effects during treatment.

BM Hyrunidase Injection is a valuable addition to medical treatments that require enhanced drug absorption and tissue healing. Its ability to aid in the dispersion and absorption of co-administered medications makes it a trusted option among healthcare professionals.